ContactDictionary

Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Stage/Subtype:  recurrent Kaposi sarcoma
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Pomalidomide in Treating Patients with Kaposi Sarcoma with or without HIV
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0047, NCI-2013-01525, 120047, P11847, PO-KS-NCI-0050, NCT01495598
Durvalumab and Tremelimumab in Treating Patients with Metastatic or Refractory Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2015-1071, NCI-2016-01178, NCT02815995
Nelfinavir Mesylate in Treating Patients with Kaposi Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 19 and over
Trial IDs: AMC-098, NCI-2016-00071, 098, NCT03077451
Nivolumab and Ipilimumab in Treating Patients with HIV Associated Solid Tumors That are Metastatic or Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: AMC-095, NCI-2015-00461, PAMC-095_R03PAPP01, NCT02408861
Pembrolizumab in Treating Patients with HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-12, NCI-2015-01906, NCT02595866
Pomalidomide and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Advanced or Refractory Kaposi Sarcoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-C-0047, NCI-2016-00067, P152279, NCT02659930
Start Over